New rehabilitation protocols based on neurotechnology that combine targeted electrical stimulation of the lumbar spinal cord and weight-assisted therapy have made three paraplegics who sustained cervical spinal cord injuries many years ago to be able to walk with the aid of crutches or a walker.
This latest study, called STIMO (STImulation Movement Overground), establishes a new therapeutic framework to improve recovery from spinal cord injury. All patients involved in the study recovered voluntary control of leg muscles that had been paralyzed for many years. Unlike the findings of two independent studies published recently in the United States on a similar concept, neurological function was shown to persist beyond training sessions even when the electrical stimulation was turned off. The STIMO study, led by the Ecole Polytechnique Fédérale de Lausanne (EPFL) and the Lausanne University Hospital (CHUV) in Switzerland, is published in the 1 November 2018 issues of Nature and Nature Neuroscience.
‘New rehabilitation protocols lead to restored neurological function in paraplegics who sustained cervical spinal cord injuries.’
"Our findings are based on a deep understanding of the underlying mechanisms which we gained through years of research on animal models. We were thus able to mimic in real time how the brain naturally activates the spinal cord," says EPFL neuroscientist Grégoire Courtine.
"All the patients could walk using body weight support within one week. I knew immediately that we were on the right path," adds CHUV neurosurgeon Jocelyne Bloch, who surgically placed the implants in the patients.
"The exact timing and location of the electrical stimulation are crucial to a patient's ability to produce an intended movement. It is also this spatiotemporal coincidence that triggers the growth of new nerve connections," says Courtine.
This study achieves an unprecedented level of precision in electrically stimulating spinal cords. "The targeted stimulation must be as precise as a Swiss watch. In our method, we implant an array of electrodes over the spinal cord which allows us to target individual muscle groups in the legs," explains Bloch. "Selected configurations of electrodes are activating specific regions of the spinal cord, mimicking the signals that the brain would deliver to produce walking."
The challenge for the patients was to learn how to coordinate their brains' intention to walk with the targeted electrical stimulation. But that did not take long. "All three study participants were able to walk with body-weight support after only one week of calibration, and voluntary muscle control improved tremendously within five months of training", says Courtine. "The human nervous system responded even more profoundly to the treatment than we expected."
Helping the brain help itself
The new rehabilitation protocols based on this targeted neurotechnology lead to improved neurological function by allowing the participants to actively train natural overground walking capabilities in the lab for extensive periods of time, as opposed to passive training like exoskeleton-assisted stepping.
During rehabilitation sessions, the three participants were able to walk hands-free over more than one kilometer with the help of targeted electrical stimulation and an intelligent bodyweight-support system. Moreover, they exhibited no leg-muscle fatigue, and so there was no deterioration in stepping quality. These longer, high-intensity training sessions proved crucial for triggering activity-dependent plasticity - the nervous system's intrinsic ability to reorganize nerve fibers - which leads to improved motor function even when the electrical stimulation is turned off.
Previous studies using more empirical approaches, such as continuous electrical stimulation protocols, have shown that a select few paraplegics can indeed take steps with the help of walking aids and electrical stimulation, but only over short distances and as long as the stimulation is on. As soon as the stimulation is turned off, the patients immediately return to their previous state of paralysis and are no longer able to activate leg movements.
The startup GTX medical, co-founded by Courtine and Bloch, will use these findings to develop tailored neurotechnology with the aim to turn this rehabilitation paradigm into a treatment available at hospitals and clinics everywhere. "We are building next-generation neurotechnology that will also be tested very early post-injury, when the potential for recovery is high and the neuromuscular system has not yet undergone the atrophy that follows chronic paralysis. Our goal is to develop a widely accessible treatment," adds Courtine.